United Therapeutics Corp (NASDAQ:UTHR)

CAPS Rating: 4 out of 5

A biotechnology company focused on the development and commercialization of innovative therapeutic products for patients with chronic and life-threatening cardiovascular, cancer and infectious diseases.

Recs

0
Player Avatar jeffro323 (99.12) Submitted: 1/6/2012 3:07:26 PM : Outperform Start Price: $48.60 UTHR Score: -12.68

Sabrient

Featured Broker Partners


Advertisement